Producing a range of comprehensive, diverse and highly complementary products, our portfolio of both generic and speciality medications that includes generics, branded generics, speciality, granules, pellets, Active Pharmaceutical Ingredients (APIs), intermediates, technical manufacturing/ package support and other technology-intensive solutions that include Finished Product, EC – Enteric Coated, ICW – In Combination With, W/W – Weight By Weight.
Producing a range of comprehensive, diverse and highly complementary products, our portfolio of both generic and speciality medications that includes generics, branded generics, speciality, granules, pellets, Active Pharmaceutical Ingredients (APIs), intermediates, technical manufacturing/ package support and other technology-intensive solutions that include Finished Product, EC – Enteric Coated, ICW – In Combination With, W/W – Weight By Weight.
Producing a range of comprehensive, diverse and highly complementary products, our portfolio of both generic and speciality medications that includes generics, branded generics, speciality, granules, pellets, Active Pharmaceutical Ingredients (APIs), intermediates, technical manufacturing/ package support and other technology-intensive solutions that include Finished Product, EC – Enteric Coated, ICW – In Combination With, W/W – Weight By Weight.
Producing a range of comprehensive, diverse and highly complementary products, our portfolio of both generic and speciality medications that includes generics, branded generics, speciality, granules, pellets, Active Pharmaceutical Ingredients (APIs), intermediates, technical manufacturing/ package support and other technology-intensive solutions that include Finished Product, EC – Enteric Coated, ICW – In Combination With, W/W – Weight By Weight.
Note: The listed products would be offered only in countries where the products do not constitute a patent infringement. However, the customer would exclusively hold the final responsibility. Enlisted products/Patent Protected products available are solely offered for experimental use or under Bolar provision strictly in compliance with the respective country law. ICW* - In Combination With
SR – Sustained Release,
DC - Directly Compressible Granules,
TM – Taste masked (Bitterless Raw Material)
Note:The listed products would be offered only in countries where the products do not constitute a patent infringements. However the customer would exclusively hold the final responsibility. Enlisted products/Patent Protected products available are solely offered for experiment use or under Bolar provision Strictly in compliance with the respective country law.
SR – Sustained Release,
DC - Directly Compressible Granules,
TM – Taste masked (Bitterless Raw Material)
Sr. No. | Product Name | ECTD Dossier (Calendar Year) | Own API Development |
---|---|---|---|
1 | Acamprosate Tabs - GR - 333mg | Available | ✓ |
2 | Amiloride Tabs - 5mg | Available | |
3 | Apixaban Tabs - 2.5mg/5mg | Available | ✓ |
4 | Carbocisteine Caps - 375mg | Available | ✓ |
5 | Colchicine Tabs - 0.5mg | Available | |
6 | Dapagliflozin Tabs - 5mg/10mg | Available | ✓ |
7 | Dapsone Tabs - 50mg/100mg | Available | |
8 | Dexlansoprazole Caps - 30mg/60mg | Available | ✓ |
9 | Empagliflozin Tabs - 25mg | Available | ✓ |
10 | Fexofenadine Tabs - 30mg/60mg/120mg/180mg | Available | |
11 | Loperamide Caps - 2mg | Available | |
12 | Methenamine Hippurate Tabs 1000mg | Available | |
13/td> | Nitrofurantoin Caps - IR - 50mg/100mg | Available | |
14 | Nitrofurantoin Caps - SR - 100mg | Available | |
15 | Prucalopride Tabs - 1mg/2mg | Available | |
16 | Trazodone Caps - IR - 50mg/100mg | Available | |
17 | Trazodone Tabs - 150mg | Available | |
18 | Edoxaban Tabs - 15mg/30mg/60mg | Q3-2025 | ✓ |
19 | Lurasidone HCL Tabs - 20mg/40mg/80mg | Q3-2025 | |
20 | Eltrombopag Olamine Tabs - 25mg/50mg/75mg | Q4-2025 | ✓ |
21 | Lisdexamfetamine Dimesylate Caps - 10mg/20mg/30mg/40mg/50mg/60mg/70mg | Q4-2025 | ✓ |
22 | Enzalutamide Tabs 80 mg | Q1-2026 | |
23 | Mirabegron Tabs - ER - 25mg / 50mg | Q1-2026 | ✓ |
24 | Vonoprazan Tabs - 10mg/ 20 mg | Q1-2026 | ✓ |
25 | Canagliflozin Tabs 300mg | Q2-2026 | |
26 | Febuxostat Tabs - 40mg / 80mg / 120mg | Q2-2026 | ✓ |
27 | Rifamixin Tabs- 100 mg/ 200 mg/ 550 mg | Q2-2026 | |
28 | Tamsulosin HCl + Solifenacin Caps - SR - 0.4mg+6mg | Q2-2026 | |
29 | Vortioxetine Hydrobromide Tabs - 5mg/10mg/20mg | Q2-2026 | ✓ |
30 | Bempedoic Acid Tabs – 180mg | Q3-2026 | ✓ |
31 | Cariprazine HCL Caps - 1.5mg / 3mg / 4.5mg / 6mg | Q3-2026 | ✓ |
32 | Bempedoic Acid + Ezetimibe Tabs - 180mg+10mg | Q4-2026 | |
33 | Rimegepant Tabs ODT 75 mg | Q4-2026 | ✓ |
34 | Rosuvastatin + Ezetimibe Tabs 10mg/ 20mg/ 40mg + 10mg | Q4-2026 | |
35 | Rouvastatin + Fenofibric acid Caps 10 + 135 mg | Q4-2026 | |
36 | Updacitinib Tabs ER - 15mg / 30mg / 45mg | Q1-2027 | ✓ |
37 | Finerenone Tabs 10 mg/20 mg | Q1-2028 | ✓ |
✔ Not available for UK Market
* Not available for UK Market Note : The listed products would be offered only in countries where the products do not constitute a patent infringements. However the customer would exclusively hold the final responsibility. Enlisted products/Patent Protected products available are solely offered for experiment use or under Bolar provision strictly in compliance with the respective country law.
The listed products would be offered only in countries where the products do not constitute a patent infringements. However the customer would exclusively hold the final responsibility. Enlisted products/Patent Protected products available are solely offered for experimental use or under Bolar provision Strictly in compliance with the respective country law.